Anti-fibrotic drug discovery / edited by Jehrod Brenneman, KSQ Therapeutics, USA and Malliga R. Iyer, National Institutes of Health, USA.
Anti-fibrotic Drug Discovery is ideal for postgraduate students and researchers with an interest in anti-fibrotic drug discovery as well as clinicians specialising in liver, kidney, heart and lung disease, in which fibrosis plays a key role in pathology.
Saved in:
Online Access: |
Full Text (via RSC) |
---|---|
Other Authors: | , |
Format: | eBook |
Language: | English |
Published: |
London :
Royal Society of Chemistry,
2020.
|
Series: | RSC drug discovery series ;
73. |
Subjects: |
Internet
Full Text (via RSC)Online
Call Number: |
RM301.25
|
---|---|
RM301.25 | Available |